Adaptive Biotechnologies Corporation
ADPT
ISIN null / Valor 48278597
Adaptive Biotechnologies Corporation
UMushroom community rating:
About company
Adaptive Biotechnologies Corporation operates at the intersection of biotechnology and computational science, focusing on harnessing the power of the adaptive immune system to develop clinical applications. The company's Immune Medicine Platform is a pioneering approach that combines proprietary chemistry, computational biology, and machine learning to decode the genetic information of a patient's immune system. By reading and interpreting the vast and complex genetic code of immune receptors, Adaptive Biotechnologies is able to generate and maintain a comprehensive database of immune receptor data. This database is dynamic, expanding with each new patient analysis, and serves as a foundational resource for the development of novel diagnostic and therapeutic tools aimed at managing and treating diseases by leveraging the body's own immune response.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
3332 M
Market cap (USD)
2,440,474
Daily traded volume (Shares)
6.225 / 5.93
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
